Literature DB >> 26761934

A review of patient adherence to topical therapies for treatment of atopic dermatitis.

Alyson Snyder1, Michael Farhangian1, Steven R Feldman2.   

Abstract

Atopic dermatitis (AD) is one of the most commonly diagnosed dermatologic conditions in the United States. Topical agents are the mainstay of treatment for AD, and when used correctly, these therapies generally are straightforward and efficacious. However, poor adherence to treatment can prevent patients from achieving disease control. This article provides a review of the literature on patient adherence to topical therapies for AD as well as a discussion of methods to improve patient adherence to treatment in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26761934

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

Review 1.  Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review.

Authors:  Sandra Ly; Jean Michel Amici
Journal:  Drugs Context       Date:  2018-08-20

2.  Treatment of non-atopic dermatitis with polarized UV-free polychromatic light: A case report.

Authors:  Alberto Leguina-Ruzzi; Kishan Rajnikant Raichura; Sarah Karis Tonks; Semira Kwabi; Claudia Leitner
Journal:  Clin Pract       Date:  2019-09-23

3.  Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.

Authors:  Simon G Danby; Paul V Andrew; Rosie N Taylor; Linda J Kay; John Chittock; Abigail Pinnock; Intisar Ulhaq; Anna Fasth; Karin Carlander; Tina Holm; Michael J Cork
Journal:  Clin Exp Dermatol       Date:  2022-04-12       Impact factor: 4.481

Review 4.  The Challenge of Managing Atopic Dermatitis in the United States.

Authors:  Steven R Feldman; Linda S Cox; Lindsay C Strowd; Robert A Gerber; Steven Faulkner; Debra Sierka; Timothy W Smith; Joseph C Cappelleri; Mark E Levenberg
Journal:  Am Health Drug Benefits       Date:  2019-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.